A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study - Yoo, D H; Hrycaj, P; Miranda, P (Ann Rheum Dis, 2013)
et al